Tirzepatide
Maximum Results with Dual GLP-1 + GIP Action
Compounded tirzepatide with B₁₂, featuring a revolutionary dual-agonist mechanism targeting both GLP-1 and GIP receptors. The most advanced weight loss medication available, prepared by a US-licensed pharmacy.
Starting at
$249/mo
22.5%
Max Avg Weight Loss
2,539
SURMOUNT-1 Participants
36%
Lost ≥25% Weight
$249
Starting Price/mo
The Power of Dual Action
Tirzepatide is the first medication to harness both GLP-1 and GIP hormones for superior weight loss
GLP-1 Receptor Activation
Reduces appetite and hunger signals in the brain, slows gastric emptying for prolonged satiety, and enhances glucose-dependent insulin secretion.
GIP Receptor Activation
Amplifies weight loss beyond GLP-1 alone, improves fat tissue metabolism and insulin sensitivity, and may reduce GI side effects through synergistic action.
Synergistic Dual Action
The combination of both pathways creates a comprehensive approach that delivers superior results compared to single-agonist medications.
SURMOUNT-1 Clinical Trial Results
The landmark study that proved Tirzepatide's superiority in weight management.
2,539
Participants
Dual
GLP-1 + GIP Action
Rx
Doctor Supervised
36%
Lost ≥25% Weight
Why Choose Tirzepatide?
Dual-Action Formula
Targets both GLP-1 and GIP receptors for a comprehensive, synergistic approach to weight management.
Superior Weight Loss
Clinical trials show up to 22.5% average weight loss — significantly more than single-agonist options.
Appetite Management
May help reduce hunger and food-related thoughts more effectively through dual hormone pathways.
Metabolic Support
May support insulin sensitivity and blood sugar management through complementary mechanisms.
Body Composition
GIP activation may support metabolic processes that help preserve lean mass during weight loss.
Provider-Guided Protocol
Your provider will customize dosing and monitor progress throughout treatment for optimal results.
Tirzepatide vs Semaglutide
Gradual Dose Escalation
Your dose increases every 4 weeks over 20+ weeks to optimize results while minimizing side effects
2.5mg weekly
Starting dose — body begins adapting to the medication
5mg weekly
First therapeutic dose — noticeable appetite reduction
7.5mg weekly
Increased efficacy — weight loss accelerates
10mg weekly
Strong therapeutic effect — significant results visible
12.5mg weekly
Higher dose for enhanced response if needed
15mg weekly
Maximum dose — peak efficacy for weight loss
Expected Results Timeline
Results vary by individual. Your physician will customize dosing based on your response and tolerance.
Frequently Asked Questions
Compounded tirzepatide (Tirz/B₁₂) contains the same active ingredient as certain brand-name medications and is prepared by a state-licensed sterile compounding pharmacy. It features a dual-agonist mechanism targeting both GLP-1 and GIP receptors. Note: Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety or efficacy.
Individual results vary significantly based on factors like starting weight, diet, exercise, adherence to treatment, and individual physiology. In the SURMOUNT-1 trial, 36% of participants lost 25% or more of their body weight. Your provider will set realistic expectations during your consultation.
The dual mechanism works through complementary pathways: GLP-1 may help reduce appetite and slow gastric emptying. GIP may add metabolic benefits. Together, these pathways offer a comprehensive approach. Your provider will explain how this may apply to your specific health situation.
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and decreased appetite. These are typically mild-to-moderate and may diminish as your body adjusts. The gradual dose escalation protocol helps minimize these effects.
Tirzepatide commands a premium price due to its newer patent status and more complex dual-agonist formulation. It targets both GLP-1 and GIP receptors, offering a comprehensive approach. For patients seeking a dual-action option, Tirzepatide may be worth the investment.
Tirzepatide is ideal for patients serious about achieving transformative weight loss. It's particularly suited for those with BMI ≥30 (or ≥27 with comorbidities), patients who want faster, more dramatic results, those who may not have achieved goals with other methods, and individuals with Type 2 diabetes or prediabetes.
Treatment begins at 2.5mg weekly for 4 weeks, then increases to 5mg for 4 weeks. After that, doses can increase in 2.5mg increments (7.5mg, 10mg, 12.5mg, 15mg) every 4 weeks based on tolerance and response. The maximum dose is 15mg weekly.
Yes, many patients successfully switch from Semaglutide to Tirzepatide, especially if they've plateaued or want enhanced results. The switch should be done under medical supervision. Typically, you would stop Semaglutide and start Tirzepatide at a low dose, following the standard titration schedule.
Ready for Maximum Results?
Transform your body with the most advanced weight loss medication available. Doctor-supervised treatment starting at $249/month.
Get Started NowFree medical consultation included • Cancel anytime